ID   PER-371
AC   CVCL_W982
DR   Wikidata; Q54947184
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=12883040;
RX   PubMed=17117183;
CC   Doubling time: 69 hours (PubMed=17117183).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D18S51: 10,17
ST   D19S433: 13,14
ST   D21S11: 31.2
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   TH01: 6
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 9
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=12883040;
RA   Kees U.R., Ford J., Watson M., Murch A.R., Ringner M., Walker R.L.,
RA   Meltzer P.S.;
RT   "Gene expression profiles in a panel of childhood leukemia cell lines
RT   mirror critical features of the disease.";
RL   Mol. Cancer Ther. 2:671-677(2003).
//
RX   PubMed=17117183; DOI=10.1038/sj.bjc.6603447; PMCID=PMC2360743;
RA   Beesley A.H., Palmer M.-L., Ford J., Weller R.E., Cummings A.J.,
RA   Freitas J.R., Firth M.J., Perera K.U., de Klerk N.H., Kees U.R.;
RT   "Authenticity and drug resistance in a panel of acute lymphoblastic
RT   leukaemia cell lines.";
RL   Br. J. Cancer 95:1537-1544(2006).
//